Screening for a diamond in the rough.

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Antimicrobial drug discovery typically eliminates compounds that disrupt the bacterial proton motive force (PMF).
• This standard approach overlooks potential therapeutic agents that modulate PMF without causing immediate bacterial lysis.
• Selective toxicity is a key challenge in developing new antibiotics.

Purpose of the Study:

• To evaluate the utility of screening for antimicrobial compounds that dissipate bacterial PMF.
• To identify molecules that selectively target bacteria by disrupting PMF while remaining non-lytic.
• To explore a novel strategy for antibiotic development.

Main Methods:

• High-throughput screening assays were employed to identify compounds affecting bacterial PMF.
• Assays were designed to differentiate between compounds that dissipate PMF and those causing bacterial lysis.
• Selective toxicity was assessed against bacterial and mammalian cells.

Main Results:

• The study successfully identified compounds that effectively dissipate bacterial PMF.
• These compounds demonstrated selective toxicity, impacting bacteria without significant harm to host cells.
• A subset of identified compounds were non-bacteriolytic, challenging the conventional screening paradigm.

Conclusions:

• Screening for PMF-dissipating compounds, even if non-lytic, is a valuable approach for antimicrobial discovery.
• This strategy expands the repertoire of potential antimicrobial agents beyond traditional bactericidal mechanisms.
• The identified compounds represent promising leads for developing novel antibiotics with a unique mechanism of action.